Package 16729-331-01

Brand: acetazolamide

Generic: acetazolamide
NDC Package

Package Facts

Identity

Package NDC 16729-331-01
Digits Only 1672933101
Product NDC 16729-331
Product ID 16729-331_45ffaa19-26c0-d41f-e063-6394a90ad7c3
Description

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16729-331-01)

Marketing

Marketing Status
Marketed Since 2021-11-19
Brand acetazolamide
Generic acetazolamide
Sample Package No

Linked Drug Pages (1)

acetazolamide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "45ffaa19-26c0-d41f-e063-6394a90ad7c3", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "unii": ["O3FX965V0I"], "rxcui": ["562524"], "spl_set_id": ["9a368b35-cd51-47ad-83cc-ccc56c4585e8"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16729-331-01)", "package_ndc": "16729-331-01", "marketing_start_date": "20211119"}], "brand_name": "acetazolamide", "product_id": "16729-331_45ffaa19-26c0-d41f-e063-6394a90ad7c3", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "16729-331", "generic_name": "acetazolamide", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "500 mg/1"}], "application_number": "ANDA207659", "marketing_category": "ANDA", "marketing_start_date": "20211119", "listing_expiration_date": "20261231"}